Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit.

The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit. Abstract Text:

    r m araR M Ara,j c packhamJ C Packham,k l haywoodK L Haywood,r m araR M Ara,j c packhamJ C Packham,k l haywoodK L Haywood,r m araR M Ara,j c packhamJ C Packham,k l haywoodK L Haywood,

    Objectives. To explore the direct healthcare resources associated with ankylosing spondylitis (AS) in the UK. A secondary objective was to establish if resources, and thus healthcare costs, vary by disease severity. Methods. Medical records of 147 sequential AS patients attending a UK secondary care rheumatology unit were examined to assess the direct healthcare resources used over the previous 12 months. Starting with a detailed inventory and measurement of resources consumed, unit cost multipliers were applied to the quantity of each type of resource consumed. The mean cost per patient was estimated using the total cost divided by the number of patients included. Results. The mean (median) annual cost per patient was pound1852 ( pound892). The distribution of cost data was skewed, with 11% of patients incurring 50% of the total costs. The three most relevant cost domains were physiotherapy, hospitalization and medication costs at 32, 21 and 20% of the total costs, respectively. Twenty percent of the patients received physiotherapy, 13% received inpatient care and almost all incurred medication costs. Thirty-four percent of patients were prescribed disease-modifying anti-rheumatic drugs and 85% non-steroidal anti-inflammatory drugs. Over 50% of patients had at least one comorbidity. Conclusion. Direct costs accelerate steeply with disease activity (Bath Ankylosing Spondylitis Disease Activity Index >6.0) and increasing loss of function (Bath Ankylosing Spondylitis Functional Index >6.0) in patients with AS. The most severely affected patients incur 50% of the total costs, and physiotherapy accounts for 32% of the total healthcare costs in the UK.

    The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit. Publishing Authors By Initials

    rm araRM Ara,jc packhamJC Packham,kl haywoodKL Haywood,rm araRM Ara,jc packhamJC Packham,kl haywoodKL Haywood,rm araRM Ara,jc packhamJC Packham,kl haywoodKL Haywood,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Rheumatology (Oxford, England)

    VOLUME: 47

    Page Numbers: 68-71

    Journal Abbreviation: Rheumatology (Oxford)

    ISSN: 1462-0332

    DAY: 13

    MONTH: Jan

    YEAR: 2008

    The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100883501

    The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit.

    AFFILIATION: Health Economics and Decision Science, ScHARR, University of Sheffield, 30 Regent Court, Sheffield S1 4DA, UK. r.m.ara@sheffield.ac.uk.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Rheumatology (Oxford)

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News